S 2262 New Jersey Senate · 2024-2025 Regular Session

Requires county health departments to maintain reserve stock of opioid antidotes to dispense to certain entities on interim basis to ensure uninterrupted supply.

This bill requires New Jersey county health departments to maintain a reserve stock of opioid antidotes (specifically naloxone) to provide to eligible entities during supply interruptions. It directly affects emergency medical response entities (like EMTs, fire departments, and ambulance services), schools with overdose policies, and professional entities (such as syringe access programs) that need immediate access to naloxone. The key mechanism mandates counties to hold these reserves for interim dispensing, ensuring uninterrupted access when regular supply chains face disruptions. The law defines "opioid antidote" as FDA-approved medications like naloxone nasal spray and specifies eligible recipients under existing prescribing rules. This focuses on maintaining consistent emergency access without expanding who may receive naloxone.
Sub-Topics: Substance Abuse
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024 Last action Jan 9, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Nick Scutari
Nick Scutari
DDemocratic
NJ
22